Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. audio stays in one workspace.
ATOS
$2.33
-5.31%
ATOS
· Atossa Therapeutics, Inc.
$2.33
-0.13 (-5.31%)
At close · Oct 8
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt as to the Company's ability to continue as a going concern. The accompanying Condensed Consolidated Financial Statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities should the Company be unable to continue as a going concern.”View the 10-Q filed Aug 7, 2026
Market Cap
$24.55M
Shares
9.98M
Volume · Oct 8
101.02K
Avg daily vol (3M)
65.24K
All webcasts
Investor Update · 2026-05-19
Atossa Therapeutics, Inc. (ATOS) May 2026 Investor Update
Research coverage
1 live source
Switch sources without leaving this page or losing your listening position.
Research materials
Open the source you need; every reader stays inside this workspace.
Listen to the call
Audio replay
Play the complete captured earnings call.
58:54
Audio
Audio replay
A speaker-labelled transcript is not available for this event yet.